Buying replicel stock thread

[ccmethinning]

They did start recruiting for Phase II, but it looks like they won't start injecting subjects until after the first trial is complete. If I were willing to get injected, and found out that phase I was a complete failure as far as regrowing hair, I am not sure that I would want to get injected all over my head so they can "see what happens". I am sure they could still fill the test slots, but people would be dropping out left and right.

That is why I highly doubt the people at Replicel said, "Gee whiz, just for the heck of it, let's see if we can get hair regrowth on the upper temples - I hope it works???"

I guess the only people they allowed into the trial are NW3/NW4 (per posters at hairsite) so maybe they chose the temples because that is one of the only areas where it would be really noticeable on a NW3/NW4.

[Maradona]

Yes, I saw that earlier today. It was all once, too, not what one would do if someone wanted to maximize their selling price. Also, sometimes an investor might have a different “risky” investment that they just had to have and decided to get out and this was money that could be invested in a different manner. We will have to keep an eye on volume and activity.
Maradona, I saw your question on Replicel’s Facebook page, it was a great question about the location of the testing – upper temples. It has really got me thinking a lot.
Okay, I am not 100% certain about this, but isn’t this supposed to be the most difficult spot to regrow hair. Even men with pretty full heads of hair will lose hair in this spot as they age. Minoxodil specifically states that it will not regrow in this region. So, why on earth would they have chosen this location?
Let’s examine a couple of scenario outcomes:
1) April results are good: Hair growth is achieved at some percentage level – let’s just assume 25%. By having the location in the upper temples, they further distinguish themselves from Minox and Propecia, their competitors. If you can truly regrow hair, why not demonstrate it an area that your current competitors have failed at and is difficult to achieve?

2) April results are bad: Replicel has failed at regrowth. Not only that, but due to the location that they selected they don’t know what it may have been like had they chosen an easier hair location to regrow hair. The stock crashes to .20/share and they cancel phase II trials not knowing what would have happened had they picked the vertex, top front, or areas that had only recently started to bald. Why in the world would they have gone this route, with it being very risky. The head scientists would never see their project through to fruition. They lose all their money when the shares crash to near zero. Not only that, they lose any prestige or standing they have in the scientific community.


I believe this makes it even more likely that they tested the procedure on someone prior to the 19 tested that we are waiting on the April results. In law, they say a good lawyer never asks a question he/she doesn’t already know the answer to. I think that applies here. Nobody in their right mind would pick the most difficult spot to regrow hair unless you were out there to prove something-something they already more or less knew the outcome of. From a business risk perspective, you generally demonstrate proof of concept on the easiest location/scenario, then go on to more difficult locations. This is a show-off statement-making proof of concept.

You read my mind bro, i was expecting an answer like the crown which is so much easier to regrow hair. But these replicel dudes picked up the most ****ed up place to grow hair, if you can grow hair in the temples or if they show results in april, I think in my opinion that bastard called MPB has its days counted 5 10 years who cares(ok not 30 i'd be dead ) i just want this mother****ed killed.

I jumped out of my seat when I read their answer I waited in agony and they said temples, i was so happy because you gotta be really confident to take down the toughest spot of MPB.

Later I realized it sounds too fishy...temples? come on, if they wanna atract investors try the crown.

Apparently replicel didn't have the purpose to treat minituarized hair only either, they wanna GROW hair from scratch because we all know there are no follicles in the temples...there may be sweat...stem cells...but certainly follicles have been raped by MPB.

So mark my words guys, if replicel shows some results in april, then its successful.

If not, it's not really over.

[lpenergy]

didn't they already start recruiting subjects for Phase II trials?

They did start recruiting for Phase II, but it looks like they won't start injecting subjects until after the first trial is complete. If I were willing to get injected, and found out that phase I was a complete failure as far as regrowing hair, I am not sure that I would want to get injected all over my head so they can "see what happens". I am sure they could still fill the test slots, but people would be dropping out left and right.

That is why I highly doubt the people at Replicel said, "Gee whiz, just for the heck of it, let's see if we can get hair regrowth on the upper temples - I hope it works???"

[NotBelievingIt]

This is certainly discouraging news, 90 000 shares dumped , looks like insider trading to me.

that's like 200 k right there, somebody chickened out .

90,000 shares is about .6% of the shares available for ownership by non-institutions and non-insiders.

In other words, hardly anything traded hands.
-----

No offense, but your reaction is a prime example of why 99.995% of people should invest in index funds only *ESPECIALLY* when the stock we are talking about is a Baby Biotech Growth stock that doesn't even have a marketable product.

Even non-baby biotech growth stocks of established companies can have wild swings but ultimately mean nothing for the long term prospects. Take a look at Dendreon (ticker symbol DNDN) since it went public and try to imagine living through some of those swings.

[2020]

The stock crashes to .20/share and they cancel phase II trials not knowing what would have happened had they picked the vertex....

didn't they already start recruiting subjects for Phase II trials?

[lpenergy]

Location of testing seems to be making a Statement

Yes, I saw that earlier today. It was all once, too, not what one would do if someone wanted to maximize their selling price. Also, sometimes an investor might have a different “risky” investment that they just had to have and decided to get out and this was money that could be invested in a different manner. We will have to keep an eye on volume and activity.
Maradona, I saw your question on Replicel’s Facebook page, it was a great question about the location of the testing – upper temples. It has really got me thinking a lot.
Okay, I am not 100% certain about this, but isn’t this supposed to be the most difficult spot to regrow hair. Even men with pretty full heads of hair will lose hair in this spot as they age. Minoxodil specifically states that it will not regrow in this region. So, why on earth would they have chosen this location?
Let’s examine a couple of scenario outcomes:
1) April results are good: Hair growth is achieved at some percentage level – let’s just assume 25%. By having the location in the upper temples, they further distinguish themselves from Minox and Propecia, their competitors. If you can truly regrow hair, why not demonstrate it an area that your current competitors have failed at and is difficult to achieve?

2) April results are bad: Replicel has failed at regrowth. Not only that, but due to the location that they selected they don’t know what it may have been like had they chosen an easier hair location to regrow hair. The stock crashes to .20/share and they cancel phase II trials not knowing what would have happened had they picked the vertex, top front, or areas that had only recently started to bald. Why in the world would they have gone this route, with it being very risky. The head scientists would never see their project through to fruition. They lose all their money when the shares crash to near zero. Not only that, they lose any prestige or standing they have in the scientific community.


I believe this makes it even more likely that they tested the procedure on someone prior to the 19 tested that we are waiting on the April results. In law, they say a good lawyer never asks a question he/she doesn’t already know the answer to. I think that applies here. Nobody in their right mind would pick the most difficult spot to regrow hair unless you were out there to prove something-something they already more or less knew the outcome of. From a business risk perspective, you generally demonstrate proof of concept on the easiest location/scenario, then go on to more difficult locations. This is a show-off statement-making proof of concept.

[Maradona]

This is certainly discouraging news, 90 000 shares dumped , looks like insider trading to me.

that's like 200 k right there, somebody chickened out .

[ccmethinning]

When there is a larger than normal sale, and the price of shares fall, there is necessarily more selling pressure than there is buying pressure, hence they were dumped.

[chrisis]

Shares aren't "dumped". If someone sold shares someone else bought them. The share price has fallen because asking/bidding price is lower.

[ccmethinning]

92,000 shares dumped today.

[chrisis]

Don't worry bosox. Just have conviction in your decision and wait until the results come out.

[BoSox]

Sorry.. guess I have a lot to learn.

[NotBelievingIt]

Did anybody notice the stock today? It dropped about 7%, should this be a concern? :/

Did you notice the rest of the stock market?

Risk mode is "off" - so any risky assets (equities in general) are being sold.

Since its low volume, any selling pressure will make a big difference in price since the bid / ask spread is so high.

Likely some skittish newb home investor dumped the shares because honestly, 1500 shares is pocket change for anyone serious about holding the company for its future prospects and thus wouldn't think twice watching ~$3000 drop 7% in value.

[2020]

On volume of 1,500? That's like $3000 worth of trading?

if that scares you then you shouldn't be involved.

^ exactly. Low volume = High volatility.

[chrisis]

On volume of 1,500? That's like $3000 worth of trading?

if that scares you then you shouldn't be involved.